PHARMACORP RX INC (PCRX.CA) Stock Earnings & Estimates
Canada - TSX-V:PCRX - CA71714X1050 - Common Stock
0.48 CAD
+0.01 (+2.13%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 5.795M | |||
| EBITDA YoY % growth | N/A | N/A | -1.298M | |
| EBIT YoY % growth | -563.2K -2,025.28% | -578K -2.63% | -1.588M -174.79% | |
| Operating Margin | N/A | N/A | -27.41% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 4.396M 1,408.48% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |